Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT2 | O75908 | 1/20 | 0.59 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.59 |
| ▸ | ICMT | O60725 | 2/20 | 0.56 |
| ▸ | ALB | P02768 | 2/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.50 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.48 |
| ▸ | TUBB | P07437 | 2/20 | 0.48 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.48 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.48 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.48 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.48 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.48 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21065463 | 1.00 | SOAT2 (0.59) | SOAT2SOAT1ICMTALBEPHX1 | |
| SCHEMBL10472081 | 0.87 | ALDH1A1 (0.54) | SOAT2SOAT1ICMTALBEPHX1 | |
| SCHEMBL30271651 | 0.87 | SOAT2 (0.56) | SOAT2SOAT1ICMTALBEPHX1 | |
| SCHEMBL19732872 | 0.87 | SOAT2 (0.56) | SOAT2SOAT1ICMTALBEPHX1 | |
| SCHEMBL19751312 | 0.87 | SOAT2 (0.56) | SOAT2SOAT1ICMTALBEPHX1 | |
| SCHEMBL6317070 | 0.87 | HPGD (0.47) | SOAT2SOAT1ICMTALBALDH1A1 | |
| SCHEMBL6317063 | 0.87 | HPGD (0.47) | SOAT2SOAT1ICMTALBALDH1A1 | |
| SCHEMBL6317067 | 0.87 | HPGD (0.47) | SOAT2SOAT1ICMTALBALDH1A1 | |
| SCHEMBL3974083 | 0.85 | SOAT2 (0.53) | SOAT2SOAT1ICMTALBEPHX1 | |
| SCHEMBL3974081 | 0.85 | SOAT2 (0.53) | SOAT2SOAT1ICMTALBEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11596626-B2 | Compound for use against pathogenic Neisseria and Haemophilus species and Moraxella catarrhalis | Universität Konstanz (DE) | 2023-03-07 | — | — | US | disclosed |
| US-20210169869-A1 | Compound for Use Against Pathogenic Neisseria and Haemophilus Species and Moraxella Catarrhalis | Universität Wien (AT) | 2021-06-10 | — | — | US | disclosed |
| EP-3728193-A1 | COMPOUND FOR USE AGAINST PATHOGENIC NEISSERIA AND HAEMOPHILUS SPECIES AND MORAXELLA CATARRHALIS | Universität Konstanz (DE) | 2020-10-28 | — | — | EP | disclosed |
| EP-3502095-A1 | COMPOUND FOR USE AGAINST PATHOGENIC NEISSERIA AND HAEMOPHILUS SPECIES AND MORAXELLA CATARRHALIS | Universität Konstanz (DE) | 2019-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11596626-B2 | Compound for use against pathogenic Neisseria and Haemophilus species and Moraxella catarrhalis | MLEC, MPO, B3GNT2 | SOAT2 3500/4885SOAT1 3315/4885ICMT 343/4885 |
| US-20210169869-A1 | Compound for Use Against Pathogenic Neisseria and Haemophilus Species and Moraxella Catarrhalis | MLEC, MPO, B3GNT2 | SOAT2 3500/4885SOAT1 3315/4885ICMT 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.